Pugh SJ - Search Results

1

Effectiveness of two doses of tick-borne encephalitis (TBE) vaccine.

Pugh SJ, Moïsi JC, Kundi M, Santonja I, Erber W, Angulo FJ, Jodar L. Pugh SJ, et al. J Travel Med. 2022 Mar 21;29(2):taab193. doi: 10.1093/jtm/taab193. J Travel Med. 2022. PMID: 34999897 No abstract available.

2

County-level Predictors of Coronavirus Disease 2019 (COVID-19) Cases and Deaths in the United States: What Happened, and Where Do We Go from Here?

McLaughlin JM, Khan F, Pugh S, Angulo FJ, Schmitt HJ, Isturiz RE, Jodar L, Swerdlow DL. McLaughlin JM, et al. Clin Infect Dis. 2021 Oct 5;73(7):e1814-e1821. doi: 10.1093/cid/ciaa1729. Clin Infect Dis. 2021. PMID: 33211797 Free PMC article.

3

County-level vaccination coverage and rates of COVID-19 cases and deaths in the United States: An ecological analysis.

McLaughlin JM, Khan F, Pugh S, Swerdlow DL, Jodar L. McLaughlin JM, et al. Lancet Reg Health Am. 2022 May;9:100191. doi: 10.1016/j.lana.2022.100191. Epub 2022 Jan 31. Lancet Reg Health Am. 2022. PMID: 35128511 Free PMC article.

4

Travelers' preferences for tick-borne encephalitis vaccination.

Poulos C, Boeri M, Coulter J, Huang L, Schley K, Pugh SJ. Poulos C, et al. Among authors: pugh sj. Expert Rev Vaccines. 2022 Oct;21(10):1495-1504. doi: 10.1080/14760584.2022.2108798. Epub 2022 Sep 25. Expert Rev Vaccines. 2022. PMID: 36154795

5

Review of vaccine effectiveness assumptions used in economic evaluations of infant pneumococcal conjugate vaccine.

Wasserman M, Sings HL, Jones D, Pugh S, Moffatt M, Farkouh R. Wasserman M, et al. Expert Rev Vaccines. 2018 Jan;17(1):71-78. doi: 10.1080/14760584.2018.1409116. Epub 2017 Nov 29. Expert Rev Vaccines. 2018. PMID: 29164952 Review.

6

Estimating the population health and economic impacts of introducing a pneumococcal conjugate vaccine in Malaysia- an economic evaluation.

Shafie AA, Ahmad N, Naidoo J, Foo CY, Wong C, Pugh S, Tan KK. Shafie AA, et al. Hum Vaccin Immunother. 2020 Jul 2;16(7):1719-1727. doi: 10.1080/21645515.2019.1701911. Epub 2020 Jan 17. Hum Vaccin Immunother. 2020. PMID: 31951782 Free PMC article.

7

Trends in vaccine investment in middle income countries.

Onishchenko K, Hill S, Wasserman M, Jones C, Moffatt M, Ruff L, Pugh SJ. Onishchenko K, et al. Among authors: pugh sj. Hum Vaccin Immunother. 2019;15(10):2378-2385. doi: 10.1080/21645515.2019.1589287. Epub 2019 Apr 12. Hum Vaccin Immunother. 2019. PMID: 30843757 Free PMC article.

8

Cost-Effectiveness of the Pneumococcal Conjugate Vaccine (10- or 13-Valent) Versus No Vaccination for a National Immunization Program in Tunisia or Algeria.

Pugh SJ, Fletcher MA, Charos A, Imekraz L, Wasserman M, Farkouh R. Pugh SJ, et al. Infect Dis Ther. 2019 Mar;8(1):63-74. doi: 10.1007/s40121-018-0226-x. Epub 2018 Dec 11. Infect Dis Ther. 2019. PMID: 30539417 Free PMC article.

9

Estimating the Impact of Switching from a Lower to Higher Valent Pneumococcal Conjugate Vaccine in Colombia, Finland, and The Netherlands: A Cost-Effectiveness Analysis.

Pugh S, Wasserman M, Moffatt M, Marques S, Reyes JM, Prieto VA, Reijnders D, Rozenbaum MH, Laine J, Åhman H, Farkouh R. Pugh S, et al. Infect Dis Ther. 2020 Jun;9(2):305-324. doi: 10.1007/s40121-020-00287-5. Epub 2020 Feb 24. Infect Dis Ther. 2020. PMID: 32096144 Free PMC article.

10

Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt.

Sevilla JP, Burnes D, El Saie RZ, Haridy H, Wasserman M, Pugh S, Perdrizet J, Bloom D. Sevilla JP, et al. Hum Vaccin Immunother. 2022 Nov 30;18(6):2114252. doi: 10.1080/21645515.2022.2114252. Epub 2022 Sep 7. Hum Vaccin Immunother. 2022. PMID: 36070504 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page